ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2016

hVMAT2: A Target of Individualized Medication for Parkinson's Disease.

Nian Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.